Back
Recursion Pharmaceuticals Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
RXRX
Recursion Pharmaceuticals
Last Price:
5.70
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight buying pressure.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.78 | Sell |
| 20-day SMA: | 6.73 | Sell |
| 50-day SMA: | 6.65 | Sell |
| 200-day SMA: | 8.36 | Sell |
| 8-day EMA: | 6.5 | Sell |
| 20-day EMA: | 6.66 | Sell |
| 50-day EMA: | 6.75 | Sell |
| 200-day EMA: | 7.72 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 40.35 | Sell |
| Chaikin Money Flow: | 241279 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.29 - 7.17) | Sell |
| Bollinger Bands (100): | (6.28 - 7.64) | Sell |
Recursion Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.04 while RXRX 8-day simple moving average is 6.78, which is a Sell signal.
- The stock price of RXRX is 6.04 while Recursion Pharmaceuticals 20-day SMA is 6.73, which makes it a Sell.
- Recursion Pharmaceuticals 50-day simple moving average is 6.65 while RXRX share price is 6.04, making it a Sell technically.
- RXRX stock price is 6.04 and Recursion Pharmaceuticals 200-day simple moving average is 8.36, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Sell
48
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Sell
The current Recursion Pharmaceuticals [RXRX] share price is $6.04. The Score for RXRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
1.73B
Price in USD:
6.04
Share Volume:
16.17M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
15.74
52-Week Low:
5.89
Sell
48
Recursion Pharmaceuticals (RXRX)
is a Sell
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 6.04 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 6.04 while RXRX 8-day exponential moving average is 6.50, which is a Sell signal.
- The stock price of RXRX is 6.04 while Recursion Pharmaceuticals 20-day EMA is 6.66, which makes it a Sell.
- Recursion Pharmaceuticals 50-day exponential moving average is 6.75 while RXRX share price is 6.04, making it a Sell technically.
- RXRX stock price is 6.04 and Recursion Pharmaceuticals 200-day simple moving average is 7.72, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Recursion Pharmaceuticals is a Sell
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 40.35, which suggest Recursion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (6.29 - 7.17), which suggest Recursion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (6.28 - 7.64), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.